CS logo
small CS logo
University of Kansas Clinical Research Center

Fairway, Kansas, United States
Cancer treatment center in Fairway, Kansas
4350 Shawnee Mission Pkwy, Fairway, KS 66205

About University of Kansas Clinical Research Center


"We have neurology, palliative care and oncology teams located within The University of Kansas Clinical Research Center in Fairway, Kansas. Clinical care and research is carried out in a collaborative environment, leading to breakthroughs in oncology care, Alzheimer's care and more."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
50
University of Kansas Medical Center
10
Pfizer
9
Eli Lilly and Company
7
Celgene
4
Jun Zhang, MD, PhD
3
NRG Oncology
3
University of Southern California
3
Astellas Pharma Global Development, Inc.
2
Catabasis Pharmaceuticals
2
Daiichi Sankyo, Inc.
2
Total Rows: 73

Clinical Trials at University of Kansas Clinical Research Center


During the past decade, University of Kansas Clinical Research Center conducted 144 clinical trials. In the 10-year time frame, 144 clinical trials started and 24 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 44 clinical trials started and 16 clinical trials were completed. i.e. 36.4% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years13132121141418183434222213138811112200114444447711Started TrialsCompleted Trails201520162017201820192020202120222023010203040
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer
2009-10-29
2024-04-13
Active, not recruiting
87
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
2010-02-08
2022-11-02
Active, not recruiting
63
A Study in Advanced Solid Tumors
2010-06-01
2015-10-01
Completed
34
Study in Advanced Solid Tumors
2010-04-01
2016-05-01
Completed
47
A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
2011-06-01
2017-10-01
Unknown status
90
A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer
2012-01-19
2015-12-25
Terminated
67
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
2011-11-01
2019-11-01
Completed
3,520
A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
2012-06-27
2019-03-04
Completed
255

Rows per page:

1–100 of 165

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "University of Kansas Clinical Research Center" #1 sponsor was "National Cancer Institute (NCI)" with 50 trials, followed by "University of Kansas Medical Center" with 10 trials sponsored, "Pfizer" with 9 trials sponsored, "Eli Lilly and Company" with 7 trials sponsored and "Celgene" with 7 trials sponsored. Other sponsors include 80 different institutions and companies that sponsored additional 73 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "University of Kansas Clinical Research Center" #1 collaborator was "National Cancer Institute (NCI)" with 9 trials as a collaborator, "Alzheimer's Therapeutic Research Institute" with 4 trials as a collaborator, "National Institute on Aging (NIA)" with 4 trials as a collaborator, "Alzheimer's Association" with 3 trials as a collaborator and "Bristol-Myers Squibb" with 3 trials as a collaborator. Other collaborators include 49 different institutions and companies that were collaborators in the rest 50 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNational CancerInstitute (NCI): 50National CancerInstitute (NCI): 50University of KansasMedical Center: 10University of KansasMedical Center: 10Pfizer: 9Pfizer: 9Eli Lilly and Company: 7Eli Lilly and Company: 7Celgene: 4Celgene: 4Jun Zhang, MD, PhD: 3Jun Zhang, MD, PhD: 3NRG Oncology: 3NRG Oncology: 3University of SouthernCalifornia: 3University of SouthernCalifornia: 3Astellas Pharma GlobalDevelopment, Inc.: 2Astellas Pharma GlobalDevelopment, Inc.: 2Catabasis Pharmaceuticals: 2Catabasis Pharmaceuticals: 2

Created with Highcharts 11.1.0Top CollaboratorsNational Cancer Institute (NCI): 9National Cancer Institute (NCI): 9Alzheimer's TherapeuticResearch Institute: 4Alzheimer's TherapeuticResearch Institute: 4National Institute onAging (NIA): 4National Institute onAging (NIA): 4Alzheimer's Association: 3Alzheimer's Association: 3Bristol-Myers Squibb: 3Bristol-Myers Squibb: 3Alzheimer's ClinicalTrials Consortium: 2Alzheimer's ClinicalTrials Consortium: 2Alzheimer's DrugDiscovery Foundation: 2Alzheimer's DrugDiscovery Foundation: 2Canadian Cancer Trials Group: 2Canadian Cancer Trials Group: 2Covance: 2Covance: 2ICON plc: 2ICON plc: 2

Clinical Trials Conditions at University of Kansas Clinical Research Center


According to Clinical.Site data, the most researched conditions in "University of Kansas Clinical Research Center" are "Acute Myeloid Leukemia" (10 trials), "Multiple Myeloma" (7 trials), "Alzheimer Disease" (6 trials), "Advanced Solid Tumors" (5 trials) and "Metastatic Malignant Solid Neoplasm" (5 trials). Many other conditions were trialed in "University of Kansas Clinical Research Center" in a lesser frequency.

Clinical Trials Intervention Types at University of Kansas Clinical Research Center


Most popular intervention types in "University of Kansas Clinical Research Center" are "Drug" (136 trials), "Biological" (43 trials), "Other" (35 trials), "Procedure" (27 trials) and "Radiation" (10 trials). Other intervention types were less common.
The name of intervention was led by "Biospecimen Collection" (21 trials), "Computed Tomography" (20 trials), "Laboratory Biomarker Analysis" (17 trials), "Nivolumab" (17 trials) and "Placebo" (17 trials). Other intervention names were less common.

Clinical Trials Genders at University of Kansas Clinical Research Center


The vast majority of trials in "University of Kansas Clinical Research Center" are 144 trials for "All" genders, 12 trials for "Male" genders and 9 trials for "Female" genders.

Clinical Trials Status at University of Kansas Clinical Research Center


Currently, there are NaN active trials in "University of Kansas Clinical Research Center". undefined are not yet recruiting, 59 are recruiting, 61 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 31 completed trials in University of Kansas Clinical Research Center, 1 suspended trials, and 9 terminated clinical trials to date.
Out of the total trials that were conducted in University of Kansas Clinical Research Center, 60 "Phase 1" clinical trials were conducted, 88 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 88Phase 2: 88Phase 1: 60Phase 1: 60Phase 3: 31Phase 3: 31Not Applicable: 3Not Applicable: 3

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 61Active, not recruiting: 61Recruiting: 59Recruiting: 59Completed: 31Completed: 31Terminated: 9Terminated: 9Unknown status: 2Unknown status: 2Enrolling by invitation: 1Enrolling by invitation: 1Suspended: 1Suspended: 1Withdrawn: 1Withdrawn: 1